- IBDEI0GM ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,7457,0)
- ;;=C7A.029^^36^368^31
- ;;^UTILITY(U,$J,358.3,7457,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7457,1,3,0)
- ;;=3^Carcinoid,Malignant,Unspec Colon
- ;;^UTILITY(U,$J,358.3,7457,1,4,0)
- ;;=4^C7A.029
- ;;^UTILITY(U,$J,358.3,7457,2)
- ;;=^5001370
- ;;^UTILITY(U,$J,358.3,7458,0)
- ;;=C7B.02^^36^368^5
- ;;^UTILITY(U,$J,358.3,7458,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7458,1,3,0)
- ;;=3^Carcinoid of Liver
- ;;^UTILITY(U,$J,358.3,7458,1,4,0)
- ;;=4^C7B.02
- ;;^UTILITY(U,$J,358.3,7458,2)
- ;;=^5001383
- ;;^UTILITY(U,$J,358.3,7459,0)
- ;;=E34.0^^36^368^6
- ;;^UTILITY(U,$J,358.3,7459,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7459,1,3,0)
- ;;=3^Carcinoid syndrome
- ;;^UTILITY(U,$J,358.3,7459,1,4,0)
- ;;=4^E34.0
- ;;^UTILITY(U,$J,358.3,7459,2)
- ;;=^19261
- ;;^UTILITY(U,$J,358.3,7460,0)
- ;;=C83.79^^36^368^33
- ;;^UTILITY(U,$J,358.3,7460,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7460,1,3,0)
- ;;=3^Lymphoma,Burkitt,Extranodal
- ;;^UTILITY(U,$J,358.3,7460,1,4,0)
- ;;=4^C83.79
- ;;^UTILITY(U,$J,358.3,7460,2)
- ;;=^5001600
- ;;^UTILITY(U,$J,358.3,7461,0)
- ;;=C83.39^^36^368^34
- ;;^UTILITY(U,$J,358.3,7461,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7461,1,3,0)
- ;;=3^Lymphoma,Diffuse large B-Cell,Extranodal
- ;;^UTILITY(U,$J,358.3,7461,1,4,0)
- ;;=4^C83.39
- ;;^UTILITY(U,$J,358.3,7461,2)
- ;;=^5001580
- ;;^UTILITY(U,$J,358.3,7462,0)
- ;;=C86.2^^36^368^35
- ;;^UTILITY(U,$J,358.3,7462,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7462,1,3,0)
- ;;=3^Lymphoma,Enteropathy T-cell type
- ;;^UTILITY(U,$J,358.3,7462,1,4,0)
- ;;=4^C86.2
- ;;^UTILITY(U,$J,358.3,7462,2)
- ;;=^5001743
- ;;^UTILITY(U,$J,358.3,7463,0)
- ;;=C82.59^^36^368^36
- ;;^UTILITY(U,$J,358.3,7463,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7463,1,3,0)
- ;;=3^Lymphoma,Follicular Diffuse,Extranodal
- ;;^UTILITY(U,$J,358.3,7463,1,4,0)
- ;;=4^C82.59
- ;;^UTILITY(U,$J,358.3,7463,2)
- ;;=^5001520
- ;;^UTILITY(U,$J,358.3,7464,0)
- ;;=C88.4^^36^368^37
- ;;^UTILITY(U,$J,358.3,7464,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7464,1,3,0)
- ;;=3^Lymphoma,MALT Type
- ;;^UTILITY(U,$J,358.3,7464,1,4,0)
- ;;=4^C88.4
- ;;^UTILITY(U,$J,358.3,7464,2)
- ;;=^5001749
- ;;^UTILITY(U,$J,358.3,7465,0)
- ;;=C83.19^^36^368^38
- ;;^UTILITY(U,$J,358.3,7465,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7465,1,3,0)
- ;;=3^Lymphoma,Mantle cell,Extranodal
- ;;^UTILITY(U,$J,358.3,7465,1,4,0)
- ;;=4^C83.19
- ;;^UTILITY(U,$J,358.3,7465,2)
- ;;=^5001570
- ;;^UTILITY(U,$J,358.3,7466,0)
- ;;=C78.6^^36^368^39
- ;;^UTILITY(U,$J,358.3,7466,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7466,1,3,0)
- ;;=3^Peritoneal carinomatosis
- ;;^UTILITY(U,$J,358.3,7466,1,4,0)
- ;;=4^C78.6
- ;;^UTILITY(U,$J,358.3,7466,2)
- ;;=^108899
- ;;^UTILITY(U,$J,358.3,7467,0)
- ;;=E85.89^^36^368^3
- ;;^UTILITY(U,$J,358.3,7467,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7467,1,3,0)
- ;;=3^Amyloidosis,Systemic
- ;;^UTILITY(U,$J,358.3,7467,1,4,0)
- ;;=4^E85.89
- ;;^UTILITY(U,$J,358.3,7467,2)
- ;;=^334034
- ;;^UTILITY(U,$J,358.3,7468,0)
- ;;=E85.81^^36^368^1
- ;;^UTILITY(U,$J,358.3,7468,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7468,1,3,0)
- ;;=3^Amyloidosis,Light Chain (AL)
- ;;^UTILITY(U,$J,358.3,7468,1,4,0)
- ;;=4^E85.81
- ;;^UTILITY(U,$J,358.3,7468,2)
- ;;=^5151302
- ;;^UTILITY(U,$J,358.3,7469,0)
- ;;=E85.82^^36^368^4
- ;;^UTILITY(U,$J,358.3,7469,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7469,1,3,0)
- ;;=3^Amyloidosis,Wild-type Transthyretin-related (ATTR)
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0GM 3745 printed Feb 18, 2025@23:14:40 Page 2
- IBDEI0GM ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,7457,0)
- +2 ;;=C7A.029^^36^368^31
- +3 ;;^UTILITY(U,$J,358.3,7457,1,0)
- +4 ;;=^358.31IA^4^2
- +5 ;;^UTILITY(U,$J,358.3,7457,1,3,0)
- +6 ;;=3^Carcinoid,Malignant,Unspec Colon
- +7 ;;^UTILITY(U,$J,358.3,7457,1,4,0)
- +8 ;;=4^C7A.029
- +9 ;;^UTILITY(U,$J,358.3,7457,2)
- +10 ;;=^5001370
- +11 ;;^UTILITY(U,$J,358.3,7458,0)
- +12 ;;=C7B.02^^36^368^5
- +13 ;;^UTILITY(U,$J,358.3,7458,1,0)
- +14 ;;=^358.31IA^4^2
- +15 ;;^UTILITY(U,$J,358.3,7458,1,3,0)
- +16 ;;=3^Carcinoid of Liver
- +17 ;;^UTILITY(U,$J,358.3,7458,1,4,0)
- +18 ;;=4^C7B.02
- +19 ;;^UTILITY(U,$J,358.3,7458,2)
- +20 ;;=^5001383
- +21 ;;^UTILITY(U,$J,358.3,7459,0)
- +22 ;;=E34.0^^36^368^6
- +23 ;;^UTILITY(U,$J,358.3,7459,1,0)
- +24 ;;=^358.31IA^4^2
- +25 ;;^UTILITY(U,$J,358.3,7459,1,3,0)
- +26 ;;=3^Carcinoid syndrome
- +27 ;;^UTILITY(U,$J,358.3,7459,1,4,0)
- +28 ;;=4^E34.0
- +29 ;;^UTILITY(U,$J,358.3,7459,2)
- +30 ;;=^19261
- +31 ;;^UTILITY(U,$J,358.3,7460,0)
- +32 ;;=C83.79^^36^368^33
- +33 ;;^UTILITY(U,$J,358.3,7460,1,0)
- +34 ;;=^358.31IA^4^2
- +35 ;;^UTILITY(U,$J,358.3,7460,1,3,0)
- +36 ;;=3^Lymphoma,Burkitt,Extranodal
- +37 ;;^UTILITY(U,$J,358.3,7460,1,4,0)
- +38 ;;=4^C83.79
- +39 ;;^UTILITY(U,$J,358.3,7460,2)
- +40 ;;=^5001600
- +41 ;;^UTILITY(U,$J,358.3,7461,0)
- +42 ;;=C83.39^^36^368^34
- +43 ;;^UTILITY(U,$J,358.3,7461,1,0)
- +44 ;;=^358.31IA^4^2
- +45 ;;^UTILITY(U,$J,358.3,7461,1,3,0)
- +46 ;;=3^Lymphoma,Diffuse large B-Cell,Extranodal
- +47 ;;^UTILITY(U,$J,358.3,7461,1,4,0)
- +48 ;;=4^C83.39
- +49 ;;^UTILITY(U,$J,358.3,7461,2)
- +50 ;;=^5001580
- +51 ;;^UTILITY(U,$J,358.3,7462,0)
- +52 ;;=C86.2^^36^368^35
- +53 ;;^UTILITY(U,$J,358.3,7462,1,0)
- +54 ;;=^358.31IA^4^2
- +55 ;;^UTILITY(U,$J,358.3,7462,1,3,0)
- +56 ;;=3^Lymphoma,Enteropathy T-cell type
- +57 ;;^UTILITY(U,$J,358.3,7462,1,4,0)
- +58 ;;=4^C86.2
- +59 ;;^UTILITY(U,$J,358.3,7462,2)
- +60 ;;=^5001743
- +61 ;;^UTILITY(U,$J,358.3,7463,0)
- +62 ;;=C82.59^^36^368^36
- +63 ;;^UTILITY(U,$J,358.3,7463,1,0)
- +64 ;;=^358.31IA^4^2
- +65 ;;^UTILITY(U,$J,358.3,7463,1,3,0)
- +66 ;;=3^Lymphoma,Follicular Diffuse,Extranodal
- +67 ;;^UTILITY(U,$J,358.3,7463,1,4,0)
- +68 ;;=4^C82.59
- +69 ;;^UTILITY(U,$J,358.3,7463,2)
- +70 ;;=^5001520
- +71 ;;^UTILITY(U,$J,358.3,7464,0)
- +72 ;;=C88.4^^36^368^37
- +73 ;;^UTILITY(U,$J,358.3,7464,1,0)
- +74 ;;=^358.31IA^4^2
- +75 ;;^UTILITY(U,$J,358.3,7464,1,3,0)
- +76 ;;=3^Lymphoma,MALT Type
- +77 ;;^UTILITY(U,$J,358.3,7464,1,4,0)
- +78 ;;=4^C88.4
- +79 ;;^UTILITY(U,$J,358.3,7464,2)
- +80 ;;=^5001749
- +81 ;;^UTILITY(U,$J,358.3,7465,0)
- +82 ;;=C83.19^^36^368^38
- +83 ;;^UTILITY(U,$J,358.3,7465,1,0)
- +84 ;;=^358.31IA^4^2
- +85 ;;^UTILITY(U,$J,358.3,7465,1,3,0)
- +86 ;;=3^Lymphoma,Mantle cell,Extranodal
- +87 ;;^UTILITY(U,$J,358.3,7465,1,4,0)
- +88 ;;=4^C83.19
- +89 ;;^UTILITY(U,$J,358.3,7465,2)
- +90 ;;=^5001570
- +91 ;;^UTILITY(U,$J,358.3,7466,0)
- +92 ;;=C78.6^^36^368^39
- +93 ;;^UTILITY(U,$J,358.3,7466,1,0)
- +94 ;;=^358.31IA^4^2
- +95 ;;^UTILITY(U,$J,358.3,7466,1,3,0)
- +96 ;;=3^Peritoneal carinomatosis
- +97 ;;^UTILITY(U,$J,358.3,7466,1,4,0)
- +98 ;;=4^C78.6
- +99 ;;^UTILITY(U,$J,358.3,7466,2)
- +100 ;;=^108899
- +101 ;;^UTILITY(U,$J,358.3,7467,0)
- +102 ;;=E85.89^^36^368^3
- +103 ;;^UTILITY(U,$J,358.3,7467,1,0)
- +104 ;;=^358.31IA^4^2
- +105 ;;^UTILITY(U,$J,358.3,7467,1,3,0)
- +106 ;;=3^Amyloidosis,Systemic
- +107 ;;^UTILITY(U,$J,358.3,7467,1,4,0)
- +108 ;;=4^E85.89
- +109 ;;^UTILITY(U,$J,358.3,7467,2)
- +110 ;;=^334034
- +111 ;;^UTILITY(U,$J,358.3,7468,0)
- +112 ;;=E85.81^^36^368^1
- +113 ;;^UTILITY(U,$J,358.3,7468,1,0)
- +114 ;;=^358.31IA^4^2
- +115 ;;^UTILITY(U,$J,358.3,7468,1,3,0)
- +116 ;;=3^Amyloidosis,Light Chain (AL)
- +117 ;;^UTILITY(U,$J,358.3,7468,1,4,0)
- +118 ;;=4^E85.81
- +119 ;;^UTILITY(U,$J,358.3,7468,2)
- +120 ;;=^5151302
- +121 ;;^UTILITY(U,$J,358.3,7469,0)
- +122 ;;=E85.82^^36^368^4
- +123 ;;^UTILITY(U,$J,358.3,7469,1,0)
- +124 ;;=^358.31IA^4^2
- +125 ;;^UTILITY(U,$J,358.3,7469,1,3,0)
- +126 ;;=3^Amyloidosis,Wild-type Transthyretin-related (ATTR)